Heron Therapeutics, Inc. (HRTX) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Heron Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.717 Good day and thank you for standing by. Welcome to the Heron Therapeutics Q1, 2026 00:00:05.717 -- 00:00:10.181 conference call. At this time, all participants are in a listen-only mode. 00:00:10.181 -- 00:00:13.264 After the speaker's presentation, there will be a question and answer session. 00:00:13.264 -- 00:00:17.829 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:17.829 -- 00:00:21.573 You will then hear an automated message advising that your hand is raised. 00:00:21.573 -- 00:00:24.576 To withdraw your question, please press star 11 again. 00:00:24.576 -- 00:00:28.263 Please be advised that today's conference is being recorded. 00:00:28.263 -- 00:00:32.648 I would now like to hand the conference over to your first speaker today, Melissa Jarrell, 00:00:32.648 -- 00:00:34.810 Vice President of Legal. You may begin. 00:00:34.810 -- 00:00:36.810 Thank 00:00:38.154 -- 00:00:42.719 you, Operator, and hello, everyone. Thank you for joining us on the Heron Therapeutics 00:00:42.719 -- 00:00:46.704 conference call today to discuss the company's financial results for the first quarter 00:00:46.704 -- 00:00:48.626 of 2026. With 00:00:48.626 -- 00:00:53.832 me today from Heron are Craig Collard, Chief Executive Officer, Ira Duarte, Executive 00:00:53.832 -- 00:00:58.143 Vice President, Chief Financial Officer, Bill Forbes, Executive Vice President, Chief 00:00:58.143 -- 00:01:03.129 Development Officer, Mark Hensley, Chief Operating Officer, and Kevin Warner, Senior 00:01:03.129 -- 00:01:06.573 Vice President, Medical Affairs, Strategy and Engagement. 00:01:06.573 -- 00:01:11.138 For those of you participating via conference call, slides are made available via webcast 00:01:11.138 -- 00:01:...